R. Singh, B. Pentland, J. Hunter, and F. Provan, Parkinson's disease and driving ability, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.4, pp.363-369, 2007.
DOI : 10.1136/jnnp.2006.103440

S. Frucht, J. Rogers, P. Greene, M. Gordon, and S. Fahn, Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole, Neurology, vol.52, issue.9, pp.1908-1918, 1999.
DOI : 10.1212/WNL.52.9.1908

M. Johns, A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, issue.6, pp.540-545, 1991.
DOI : 10.1093/sleep/14.6.540

M. Johns, Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of the MSLT as a gold standard, Journal of Sleep Research, vol.9, issue.1, pp.5-11, 2000.
DOI : 10.1046/j.1365-2869.2000.00177.x

D. Hobson, A. Lang, W. Martin, W. Razmy, A. Rivest et al., Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease, JAMA, vol.287, issue.4, pp.455-63, 2002.
DOI : 10.1001/jama.287.4.455

W. Ondo, D. Vuong, K. Khan, H. Atassi, F. Kwak et al., Daytime sleepiness and other sleep disorders in Parkinson's disease, Neurology, vol.57, issue.8, pp.1392-1398, 2001.
DOI : 10.1212/WNL.57.8.1392

E. Tan, S. Lum, S. Fook-chong, M. Teoh, Y. Yih et al., Evaluation of somnolence in Parkinson's disease: Comparison with age- and sex-matched controls, Neurology, vol.58, issue.3, pp.465-473, 2002.
DOI : 10.1212/WNL.58.3.465

I. Ghorayeb, A. Loundou, P. Auquier, Y. Dauvilliers, B. Bioulac et al., A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France, Movement Disorders, vol.21, issue.11, pp.1567-72, 2007.
DOI : 10.1002/mds.21541

M. Gjerstad, D. Aarsland, and J. Larsen, Development of daytime somnolence over time in Parkinson's disease, Neurology, vol.58, issue.10, pp.1544-1550, 2002.
DOI : 10.1212/WNL.58.10.1544

R. Abbott, G. Ross, L. White, C. Tanner, K. Masaki et al., Excessive daytime sleepiness and subsequent development of Parkinson disease, Neurology, vol.65, issue.9, pp.1442-1448, 2005.
DOI : 10.1212/01.wnl.0000183056.89590.0d

Y. Korner, C. Meindorfner, J. Moller, K. Stiasny-kolster, D. Haja et al., Predictors of sudden onset of sleep in Parkinson's disease, Movement Disorders, vol.17, issue.11, pp.1298-305, 2004.
DOI : 10.1002/mds.20163

A. Razmy, A. Lang, and C. Shapiro, Predictors of Impaired Daytime Sleep and Wakefulness in Patients With Parkinson Disease Treated With Older (Ergot) vs Newer (Nonergot) Dopamine Agonists, Archives of Neurology, vol.61, issue.1, pp.97-102, 2004.
DOI : 10.1001/archneur.61.1.97

M. Merino-andreu, I. Arnulf, E. Konofal, J. Derenne, and Y. Agid, Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness, Neurology, vol.60, issue.9, pp.1553-1557, 2003.
DOI : 10.1212/01.WNL.0000058905.71369.97

I. Arnulf, A. Bonnet, P. Damier, P. Bejjani, D. Seilhean et al., Hallucinations, REM sleep, and Parkinson's disease: A medical hypothesis, Neurology, vol.55, issue.2, pp.281-289, 2000.
DOI : 10.1212/WNL.55.2.281

D. Rye, D. Bliwise, B. Dihenia, and P. Gurecki, Daytime sleepiness in Parkinson's disease, Journal of Sleep Research, vol.9, issue.1, pp.63-72, 2000.
DOI : 10.1046/j.1365-2869.2000.00201.x

C. De-cock, V. Abouda, M. Leu, S. Oudiette, D. et al., Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med, 2009.

D. Cock, V. Vidailhet, M. Leu, S. Texeira, A. Apartis et al., Restoration of normal motor control in Parkinson's disease during REM sleep, Brain, vol.130, issue.2, pp.450-456, 2007.
DOI : 10.1093/brain/awl363

K. Jellinger, Pathology of Parkinson???s disease, Molecular and Chemical Neuropathology, vol.24, issue.Suppl., pp.153-97, 1991.
DOI : 10.1007/BF03159935

E. Hirsch, A. Graybiel, C. Duyckaerts, and F. Javoy-agid, Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy., Proceedings of the National Academy of Sciences, vol.84, issue.16, pp.5976-80, 1987.
DOI : 10.1073/pnas.84.16.5976

T. Thannickal, Y. Lai, and J. Siegel, Hypocretin (orexin) cell loss in Parkinson's disease, Brain, vol.130, issue.6, pp.1586-95, 2007.
DOI : 10.1093/brain/awm097

M. Garbarg, F. Javoy-agid, J. Schwartz, and Y. Agid, BRAIN HISTIDINE DECARBOXYLASE ACTIVITY IN PARKINSON'S DISEASE, The Lancet, vol.321, issue.8314-8315, pp.74-79, 1983.
DOI : 10.1016/S0140-6736(83)91613-6

P. Damier, E. Hirsch, Y. Agid, and A. Graybiel, The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease, Brain, vol.122, issue.8, pp.1437-1485, 1999.
DOI : 10.1093/brain/122.8.1437

J. Avorn, S. Schneeweiss, L. Sudarsky, J. Benner, Y. Kiyota et al., Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease, Archives of Neurology, vol.62, issue.8, pp.1242-1250, 2005.
DOI : 10.1001/archneur.62.8.1242

J. Micallef, M. Rey, A. Eusebio, C. Audebert, F. Rouby et al., Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects, British Journal of Clinical Pharmacology, vol.284, issue.3, pp.333-373, 2009.
DOI : 10.1111/j.1365-2125.2008.03310.x

R. Pahwa, M. Stacy, S. Factor, K. Lyons, F. Stocchi et al., Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease, Neurology, vol.68, issue.14, pp.1108-1123, 2007.
DOI : 10.1212/01.wnl.0000258660.74391.c1

W. Poewe, O. Rascol, N. Quinn, E. Tolosa, W. Oertel et al., Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial, The Lancet Neurology, vol.6, issue.6, pp.513-533, 2007.
DOI : 10.1016/S1474-4422(07)70108-4

C. Trenkwalder, D. Garcia-borreguero, P. Montagna, E. Lainey, A. De-weerd et al., Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries, J Neurol Neurosurg Psychiatry, vol.75, pp.92-99, 2004.

G. Fabbrini, P. Barbanti, C. Aurilia, C. Pauletti, N. Vanacore et al., Excessive daytime somnolence in Parkinson?s disease. Follow-up after 1 year of treatment, Neurological Sciences, vol.24, issue.3, pp.178-187, 2003.
DOI : 10.1007/s10072-003-0118-y

C. Comella, M. Morrissey, and K. Janko, Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy, Neurology, vol.64, issue.8, pp.1450-1451, 2005.
DOI : 10.1212/01.WNL.0000158652.74601.48

J. Monti, M. Hawkins, H. Jantos, D. Angelo, L. Fernandez et al., Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat, Psychopharmacology, vol.95, issue.3, pp.395-400, 1988.
DOI : 10.1007/BF00181955

C. Alberto, R. Trask, M. Quinlan, and M. Hirasawa, Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons, Journal of Neuroscience, vol.26, issue.39, pp.10043-50, 2006.
DOI : 10.1523/JNEUROSCI.1819-06.2006

M. Carskadon, M. Mitler, and T. Roth, Guidelines for the Multiple Sleep Latency Test (MSLT) : a standard measure of sleepiness, Sleep, vol.9, pp.519-543, 1986.

W. Ondo, R. Fayle, F. Atassi, and J. Jankovic, Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.12, pp.1636-1645, 2005.
DOI : 10.1136/jnnp.2005.065870

W. Ondo, T. Perkins, T. Swick, K. Hull, J. Jimenez et al., Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease, Archives of Neurology, vol.65, issue.10, pp.1337-1377, 2008.
DOI : 10.1001/archneur.65.10.1337

D. Devos, P. Krystkowiak, F. Clement, K. Dujardin, O. Cottencin et al., Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.5, pp.470-475, 2007.
DOI : 10.1136/jnnp.2006.100016

J. Lin, Y. Dauvilliers, I. Arnulf, H. Bastuji, C. Anaclet et al., An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin???/??? mice and patients, Neurobiology of Disease, vol.30, issue.1, pp.74-83, 2008.
DOI : 10.1016/j.nbd.2007.12.003
URL : https://hal.archives-ouvertes.fr/inserm-00215993

I. Arnulf, S.19.05 Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease, European Neuropsychopharmacology, vol.19, p.204, 2009.
DOI : 10.1016/S0924-977X(09)70268-8

A. Lim, E. Moro, A. Lozano, C. Hamani, J. Dostrovsky et al., Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons, Annals of Neurology, vol.91, issue.1, pp.110-114, 2009.
DOI : 10.1002/ana.21631

A. Stefani, R. Ceravelo, L. Brusa, M. Pierantozzi, A. Costa et al., Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains, J Neurol Sci, 2009.

I. Arnulf, M. Ferraye, V. Fraix, S. Chabardès, C. Goetz et al., Sleep induced by stimulation in the human pedunculopontine nucleus area, Annals of Neurology, vol.15, issue.4, 2009.
DOI : 10.1002/ana.21912
URL : https://hal.archives-ouvertes.fr/inserm-00528797

C. Saper, T. Scammell, and J. Lu, Hypothalamic regulation of sleep and circadian rhythms, Nature, vol.281, issue.7063, pp.1257-63, 2005.
DOI : 10.1146/annurev.pharmtox.44.101802.121429

K. Jellinger, Pathology of Parkinson???s disease, Molecular and Chemical Neuropathology, vol.24, issue.Suppl., pp.55-72, 2001.
DOI : 10.1007/BF03159935